Literature DB >> 24608376

De novo large genomic deletions involving POU3F4 in incomplete partition type III inner ear anomaly in East Asian populations and implications for genetic counseling.

Jin Woong Choi1, ByungJoo Min, AhReum Kim, Ja-Won Koo, Chong-Sun Kim, Woong-Yang Park, Juyong Chung, Veronica Kim, Yoon-Jong Ryu, Shin Hye Kim, Sun-O Chang, Seung-Ha Oh, Byung Yoon Choi.   

Abstract

OBJECTIVE: The aim of this study was to understand the prevalence and molecular genetic etiology of incomplete partition type III (IP type III) anomaly in Koreans. We also attempted to verify the prevalence of genomic deletions in the DFNX2 locus and to look for association between inheritance patterns and mutation type in East Asian IP type III subjects. STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: Subjects with IP type III anomaly and their biological mothers.
INTERVENTIONS: Sanger sequencing, array-comparative genomic hybridization (aCGH), and PCR were performed. We also analyzed the type and inheritance of the causative genetic abnormality in East Asian DFNX2 patients. MAIN OUTCOME MEASURE: Mutation type and occurrence.
RESULTS: We identified IP type III in 10 (4.8%) of 206 patients with an inner ear abnormality. We confirmed an etiologic homogeneity, DFNX2, of the IP type III in this Korean population. Two (20%) of the 10 DFNX2 carried a large genomic deletion affecting POU3F4, as proved by aCGH. PCR confirmed that the 2 deletions occurred de novo. Genetic alteration occurred de novo in 29.4% (5/17) of all reported Korean IP type III cases. From this study and literature review, we observed a striking difference of de novo occurrence rate (75% versus 12.5%, p = 0.032) between large genomic deletions and point mutations in East Asian population.
CONCLUSIONS: Our data suggest that different POU3F4 mutations might show different recurrence rate in siblings of the IP type III families, especially in East Asian population. Genetic counseling should be provided accordingly.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24608376     DOI: 10.1097/MAO.0000000000000343

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  9 in total

1.  Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.

Authors:  Andrea M Oza; Marina T DiStefano; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Jaclyn B Murry; Linda Hasadsri; Kiyomitsu Nara; Margaret Kenna; Kevin T Booth; Hela Azaiez; Andrew Griffith; Karen B Avraham; Hannie Kremer; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

2.  De novo mutation in X-linked hearing loss-associated POU3F4 in a sporadic case of congenital hearing loss.

Authors:  Hideaki Moteki; A Eliot Shearer; Shuji Izumi; Yamato Kubota; Hela Azaiez; Kevin T Booth; Christina M Sloan; Diana L Kolbe; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-19       Impact factor: 1.547

Review 3.  New Imaging Findings of Incomplete Partition Type III Inner Ear Malformation and Literature Review.

Authors:  R Hong; Q Du; Y Pan
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

4.  Exploration of molecular genetic etiology for Korean cochlear implantees with severe to profound hearing loss and its implication.

Authors:  Joo Hyun Park; Nayoung K D Kim; Ah Reum Kim; Jihye Rhee; Seung Ha Oh; Ja-Won Koo; Jae-Yong Nam; Woong-Yang Park; Byung Yoon Choi
Journal:  Orphanet J Rare Dis       Date:  2014-11-06       Impact factor: 4.123

5.  Phenotypic and genetic characterization of a family carrying two Xq21.1-21.3 interstitial deletions associated with syndromic hearing loss.

Authors:  Sandra Iossa; Valerio Costa; Virginia Corvino; Gennaro Auletta; Luigi Barruffo; Stefania Cappellani; Carlo Ceglia; Giovanni Cennamo; Adamo Pio D'Adamo; Alessandra D'Amico; Nilde Di Paolo; Raimondo Forte; Paolo Gasparini; Carla Laria; Barbara Lombardo; Rita Malesci; Andrea Vitale; Elio Marciano; Annamaria Franzè
Journal:  Mol Cytogenet       Date:  2015-03-20       Impact factor: 2.009

6.  A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family.

Authors:  Wan Du; Ming-Kun Han; Da-Yong Wang; Bing Han; Liang Zong; Lan Lan; Ju Yang; Qi Shen; Lin-Yi Xie; Lan Yu; Jing Guan; Qiu-Ju Wang
Journal:  Chin Med J (Engl)       Date:  2017-01-05       Impact factor: 2.628

Review 7.  X-Linked Sensorineural Hearing Loss: A Literature Review.

Authors:  Virginia Corvino; Pasqualina Apisa; Rita Malesci; Carla Laria; Gennaro Auletta; Annamaria Franzé
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

8.  Powerful use of automated prioritization of candidate variants in genetic hearing loss with extreme etiologic heterogeneity.

Authors:  So Young Kim; Seungmin Lee; Go Hun Seo; Bong Jik Kim; Doo Yi Oh; Jin Hee Han; Moo Kyun Park; So Min Lee; Bonggi Kim; Nayoung Yi; Namju Justin Kim; Doo Hyun Koh; Sohyun Hwang; Changwon Keum; Byung Yoon Choi
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

9.  Genetic findings of Sanger and nanopore single-molecule sequencing in patients with X-linked hearing loss and incomplete partition type III.

Authors:  Ying Chen; Jiajun Qiu; Yingwei Wu; Huan Jia; Yi Jiang; Mengda Jiang; Zhili Wang; Hai-Bin Sheng; Lingxiang Hu; Zhihua Zhang; Zhaoyan Wang; Yun Li; Zhiwu Huang; Hao Wu
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.